HT
PTCT icon

HAP Trading’s PTC Therapeutics PTCT Stock Holding History

HAP Trading’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-172,500
Closed -$91K – 1578
2022
Q4 		$91K Buy
+172,500
New +$7.17M 0.01% 596
2020
Q1 		– Sell
-13,400
Closed -$35K – 1455
2019
Q4 		$35K Buy
+13,400
New +$569K ﹤0.01% 772
2019
Q3 		– Sell
-54,800
Closed -$269K – 1351
2019
Q2 		$269K Buy
+54,800
New +$2.16M 0.02% 450
2017
Q4 		– Sell
-191,200
Closed -$496K – 1130
2017
Q3 		$496K Buy
+191,200
New +$3.74M 0.02% 357
2017
Q2 		– Sell
-24,300
Closed -$14K – 1127
2017
Q1 		$14K Buy
+24,300
New +$294K ﹤0.01% 878
2016
Q2 		– Sell
-24,400
Closed -$8K – 1016
2016
Q1 		$8K Sell
24,400
-7,700
-24% -$134K ﹤0.01% 689
2015
Q4 		$96K Sell
32,100
-23,400
-42% -$689K ﹤0.01% 561
2015
Q3 		$109K Buy
+55,500
New +$2.37M 0.01% 599

Other funds holding PTCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

HAP Trading's PTCT Position: Q2 2017 in Review

HAP Trading sold out of PTC Therapeutics (PTCT) in Q2 2017, closing a stake of 101,707 shares — an estimated $1M sold.

HAP Trading first reported a position in PTCT in Q1 2017 and held it in 1 quarter. The position peaked at $1M in Q1 2017. 114 funds tracked by Wall St. Rank hold PTCT as of Q2 2017.

  • HAP Trading reported no remaining PTC Therapeutics position as of Q2 2017 after selling out during the quarter.
  • HAP Trading sold 101,707 PTC Therapeutics shares in Q2 2017, an estimated $1M.
  • HAP Trading first reported a position in PTC Therapeutics in Q1 2017 and held it in 1 quarter.
  • HAP Trading's PTC Therapeutics position peaked at $1M in Q1 2017.
  • 114 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2017.

Based on HAP Trading's 13F filing for Q2 2017, filed 10 Aug 2017.